APO Research
Talk to an analyst

APO RESEARCH · REPORT

Coptis Pill for Clearing the Upper

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Coptis Pill for Clearing the Upper Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025191 pages

Choose your research edition.

Industry ResearchCoptis Pill for Clearing the Upper Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Coptis Pill for Clearing the Upper Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Coptis Pill for Clearing the Upper Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coptis Pill for Clearing the Upper Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Coptis Pill for Clearing the Upper Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Coptis Pill for Clearing the Upper market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Coptis Pill for Clearing the Upper is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Coptis Pill for Clearing the Upper is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Coptis Pill for Clearing the Upper is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Coptis Pill for Clearing the Upper is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Coptis Pill for Clearing the Upper include Chongqing Dongfang Pharmaceutical Co., Ltd., Xi'an Beilin Pharmaceutical Co., Ltd., Tonghua Yongji Pharmaceutical Co., Ltd., Shaanxi Xiangju Pharmaceutical Group Co., Ltd., Shaanxi Hanwang Pharmaceutical Co., Ltd., Shanxi Zhenglai Pharmaceutical Co., Ltd., Shanxi Wanhui Pharmaceutical Co., Ltd., Shanxi Huakang Pharmaceutical Co., Ltd. and Shandong Wohua Pharmaceutical Technology Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Coptis Pill for Clearing the Upper market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Coptis Pill for Clearing the Upper and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Coptis Pill for Clearing the Upper sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Coptis Pill for Clearing the Upper market size, projected growth trends, production technologies, key applications, and end-use industries.

Coptis Pill for Clearing the Upper Segment by Company

Chongqing Dongfang Pharmaceutical Co., Ltd.

Xi'an Beilin Pharmaceutical Co., Ltd.

Tonghua Yongji Pharmaceutical Co., Ltd.

Shaanxi Xiangju Pharmaceutical Group Co., Ltd.

Shaanxi Hanwang Pharmaceutical Co., Ltd.

Shanxi Zhenglai Pharmaceutical Co., Ltd.

Shanxi Wanhui Pharmaceutical Co., Ltd.

Shanxi Huakang Pharmaceutical Co., Ltd.

Shandong Wohua Pharmaceutical Technology Co., Ltd.

Shandong Huayang Pharmaceutical Co., Ltd.

Inner Mongolia Datang Pharmaceutical Co., Ltd.

Lanzhou Foci Pharmaceutical Co., Ltd.

Jilin Yinhe Pharmaceutical Co., Ltd.

Hubei Xianglian Pharmaceutical Co., Ltd.

Henan Longdu Pharmaceutical Co., Ltd.

Harbin Pharmaceutical Group Traditional Chinese Medicine Factory No. 2

Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory

Sinopharm Group Zhonglian Pharmaceutical Co., Ltd.

Gansu Tianshui Qihuang Pharmaceutical Co., Ltd.

Gansu Hexi Pharmaceutical Co., Ltd.

Gansu Fuzheng Pharmaceutical Technology Co., Ltd.

Dong'e Ejiao Co., Ltd.

Beijing Tongrentang Co., Ltd.

Coptis Pill for Clearing the Upper Segment by Type

4g

6g

Coptis Pill for Clearing the Upper Segment by Application

Hospital

Clinic

Other

Coptis Pill for Clearing the Upper Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coptis Pill for Clearing the Upper market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coptis Pill for Clearing the Upper and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coptis Pill for Clearing the Upper.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Coptis Pill for Clearing the Upper market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Coptis Pill for Clearing the Upper manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Coptis Pill for Clearing the Upper in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Coptis Pill for Clearing the Upper in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Coptis Pill for Clearing the Upper Industry Trends Table 2. Coptis Pill for Clearing the Upper Industry Drivers Table 3. Coptis Pill for Clearing the Upper Industry Opportunities and Challenges Table 4. Coptis Pill for Clearing the Upper Industry Restraints Table 5. Global Coptis Pill for Clearing the Upper Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Coptis Pill for Clearing the Upper Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Coptis Pill for Clearing the Upper Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Coptis Pill for Clearing the Upper Sales Market Share by Manufacturers Table 9. Global Coptis Pill for Clearing the Upper Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Coptis Pill for Clearing the Upper Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Coptis Pill for Clearing the Upper Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Coptis Pill for Clearing the Upper Manufacturers, Product Type & Application Table 13. Global Coptis Pill for Clearing the Upper Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Coptis Pill for Clearing the Upper by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 4g Table 17. Major Manufacturers of 6g Table 18. Global Coptis Pill for Clearing the Upper Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Coptis Pill for Clearing the Upper Sales by Type (2021-2026) & (K Units) Table 20. Global Coptis Pill for Clearing the Upper Sales by Type (2027-2032) & (K Units) Table 21. Global Coptis Pill for Clearing the Upper Sales Market Share by Type (2021-2026) Table 22. Global Coptis Pill for Clearing the Upper Sales Market Share by Type (2027-2032) Table 23. Global Coptis Pill for Clearing the Upper Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Coptis Pill for Clearing the Upper Revenue by Type (2021-2026) & (K Units) Table 25. Global Coptis Pill for Clearing the Upper Revenue by Type (2027-2032) & (K Units) Table 26. Global Coptis Pill for Clearing the Upper Revenue Market Share by Type (2021-2026) Table 27. Global Coptis Pill for Clearing the Upper Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Other Table 31. Global Coptis Pill for Clearing the Upper Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Coptis Pill for Clearing the Upper Sales by Application (2021-2026) & (K Units) Table 33. Global Coptis Pill for Clearing the Upper Sales by Application (2027-2032) & (K Units) Table 34. Global Coptis Pill for Clearing the Upper Sales Market Share by Application (2021-2026) Table 35. Global Coptis Pill for Clearing the Upper Sales Market Share by Application (2027-2032) Table 36. Global Coptis Pill for Clearing the Upper Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Coptis Pill for Clearing the Upper Revenue by Application (2021-2026) & (K Units) Table 38. Global Coptis Pill for Clearing the Upper Revenue by Application (2027-2032) & (K Units) Table 39. Global Coptis Pill for Clearing the Upper Revenue Market Share by Application (2021-2026) Table 40. Global Coptis Pill for Clearing the Upper Revenue Market Share by Application (2027-2032) Table 41. Global Coptis Pill for Clearing the Upper Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Coptis Pill for Clearing the Upper Sales by Region (2021-2026) & (K Units) Table 43. Global Coptis Pill for Clearing the Upper Sales Market Share by Region (2021-2026) Table 44. Global Coptis Pill for Clearing the Upper Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Coptis Pill for Clearing the Upper Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Coptis Pill for Clearing the Upper Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Coptis Pill for Clearing the Upper Sales by Country (2021-2026) & (K Units) Table 48. North America Coptis Pill for Clearing the Upper Sales by Country (2027-2032) & (K Units) Table 49. Europe Coptis Pill for Clearing the Upper Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Coptis Pill for Clearing the Upper Sales by Country (2021-2026) & (K Units) Table 51. Europe Coptis Pill for Clearing the Upper Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Coptis Pill for Clearing the Upper Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Coptis Pill for Clearing the Upper Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Coptis Pill for Clearing the Upper Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Coptis Pill for Clearing the Upper Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Coptis Pill for Clearing the Upper Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Coptis Pill for Clearing the Upper Sales by Country (2027-2032) & (K Units) Table 58. Global Coptis Pill for Clearing the Upper Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Coptis Pill for Clearing the Upper Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Coptis Pill for Clearing the Upper Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Coptis Pill for Clearing the Upper Revenue Market Share by Region (2021-2026) Table 62. Global Coptis Pill for Clearing the Upper Revenue Market Share by Region (2027-2032) Table 63. Chongqing Dongfang Pharmaceutical Co., Ltd. Company Information Table 64. Chongqing Dongfang Pharmaceutical Co., Ltd. Business Overview Table 65. Chongqing Dongfang Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Chongqing Dongfang Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio Table 67. Chongqing Dongfang Pharmaceutical Co., Ltd. Recent Development Table 68. Xi'an Beilin Pharmaceutical Co., Ltd. Company Information Table 69. Xi'an Beilin Pharmaceutical Co., Ltd. Business Overview Table 70. Xi'an Beilin Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Xi'an Beilin Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio Table 72. Xi'an Beilin Pharmaceutical Co., Ltd. Recent Development Table 73. Tonghua Yongji Pharmaceutical Co., Ltd. Company Information Table 74. Tonghua Yongji Pharmaceutical Co., Ltd. Business Overview Table 75. Tonghua Yongji Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Tonghua Yongji Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio Table 77. Tonghua Yongji Pharmaceutical Co., Ltd. Recent Development Table 78. Shaanxi Xiangju Pharmaceutical Group Co., Ltd. Company Information Table 79. Shaanxi Xiangju Pharmaceutical Group Co., Ltd. Business Overview Table 80. Shaanxi Xiangju Pharmaceutical Group Co., Ltd. Coptis Pill for Clearing the Upper Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Shaanxi Xiangju Pharmaceutical Group Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio Table 82. Shaanxi Xiangju Pharmaceutical Group Co., Ltd. Recent Development Table 83. Shaanxi Hanwang Pharmaceutical Co., Ltd. Company Information Table 84. Shaanxi Hanwang Pharmaceutical Co., Ltd. Business Overview Table 85. Shaanxi Hanwang Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Shaanxi Hanwang Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio Table 87. Shaanxi Hanwang Pharmaceutical Co., Ltd. Recent Development Table 88. Shanxi Zhenglai Pharmaceutical Co., Ltd. Company Information Table 89. Shanxi Zhenglai Pharmaceutical Co., Ltd. Business Overview Table 90. Shanxi Zhenglai Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Shanxi Zhenglai Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio Table 92. Shanxi Zhenglai Pharmaceutical Co., Ltd. Recent Development Table 93. Shanxi Wanhui Pharmaceutical Co., Ltd. Company Information Table 94. Shanxi Wanhui Pharmaceutical Co., Ltd. Business Overview Table 95. Shanxi Wanhui Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Shanxi Wanhui Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio Table 97. Shanxi Wanhui Pharmaceutical Co., Ltd. Recent Development Table 98. Shanxi Huakang Pharmaceutical Co., Ltd. Company Information Table 99. Shanxi Huakang Pharmaceutical Co., Ltd. Business Overview Table 100. Shanxi Huakang Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Shanxi Huakang Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio Table 102. Shanxi Huakang Pharmaceutical Co., Ltd. Recent Development Table 103. Shandong Wohua Pharmaceutical Technology Co., Ltd. Company Information Table 104. Shandong Wohua Pharmaceutical Technology Co., Ltd. Business Overview Table 105. Shandong Wohua Pharmaceutical Technology Co., Ltd. Coptis Pill for Clearing the Upper Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Shandong Wohua Pharmaceutical Technology Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio Table 107. Shandong Wohua Pharmaceutical Technology Co., Ltd. Recent Development Table 108. Shandong Huayang Pharmaceutical Co., Ltd. Company Information Table 109. Shandong Huayang Pharmaceutical Co., Ltd. Business Overview Table 110. Shandong Huayang Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Shandong Huayang Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio Table 112. Shandong Huayang Pharmaceutical Co., Ltd. Recent Development Table 113. Inner Mongolia Datang Pharmaceutical Co., Ltd. Company Information Table 114. Inner Mongolia Datang Pharmaceutical Co., Ltd. Business Overview Table 115. Inner Mongolia Datang Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Inner Mongolia Datang Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio Table 117. Inner Mongolia Datang Pharmaceutical Co., Ltd. Recent Development Table 118. Lanzhou Foci Pharmaceutical Co., Ltd. Company Information Table 119. Lanzhou Foci Pharmaceutical Co., Ltd. Business Overview Table 120. Lanzhou Foci Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Lanzhou Foci Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio Table 122. Lanzhou Foci Pharmaceutical Co., Ltd. Recent Development Table 123. Jilin Yinhe Pharmaceutical Co., Ltd. Company Information Table 124. Jilin Yinhe Pharmaceutical Co., Ltd. Business Overview Table 125. Jilin Yinhe Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Jilin Yinhe Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio Table 127. Jilin Yinhe Pharmaceutical Co., Ltd. Recent Development Table 128. Hubei Xianglian Pharmaceutical Co., Ltd. Company Information Table 129. Hubei Xianglian Pharmaceutical Co., Ltd. Business Overview Table 130. Hubei Xianglian Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Hubei Xianglian Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio Table 132. Hubei Xianglian Pharmaceutical Co., Ltd. Recent Development Table 133. Henan Longdu Pharmaceutical Co., Ltd. Company Information Table 134. Henan Longdu Pharmaceutical Co., Ltd. Business Overview Table 135. Henan Longdu Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Henan Longdu Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio Table 137. Henan Longdu Pharmaceutical Co., Ltd. Recent Development Table 138. Harbin Pharmaceutical Group Traditional Chinese Medicine Factory No. 2 Company Information Table 139. Harbin Pharmaceutical Group Traditional Chinese Medicine Factory No. 2 Business Overview Table 140. Harbin Pharmaceutical Group Traditional Chinese Medicine Factory No. 2 Coptis Pill for Clearing the Upper Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Harbin Pharmaceutical Group Traditional Chinese Medicine Factory No. 2 Coptis Pill for Clearing the Upper Product Portfolio Table 142. Harbin Pharmaceutical Group Traditional Chinese Medicine Factory No. 2 Recent Development Table 143. Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Company Information Table 144. Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Business Overview Table 145. Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Coptis Pill for Clearing the Upper Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Coptis Pill for Clearing the Upper Product Portfolio Table 147. Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Recent Development Table 148. Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Company Information Table 149. Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Business Overview Table 150. Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio Table 152. Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Recent Development Table 153. Gansu Tianshui Qihuang Pharmaceutical Co., Ltd. Company Information Table 154. Gansu Tianshui Qihuang Pharmaceutical Co., Ltd. Business Overview Table 155. Gansu Tianshui Qihuang Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Gansu Tianshui Qihuang Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio Table 157. Gansu Tianshui Qihuang Pharmaceutical Co., Ltd. Recent Development Table 158. Gansu Hexi Pharmaceutical Co., Ltd. Company Information Table 159. Gansu Hexi Pharmaceutical Co., Ltd. Business Overview Table 160. Gansu Hexi Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Gansu Hexi Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio Table 162. Gansu Hexi Pharmaceutical Co., Ltd. Recent Development Table 163. Gansu Fuzheng Pharmaceutical Technology Co., Ltd. Company Information Table 164. Gansu Fuzheng Pharmaceutical Technology Co., Ltd. Business Overview Table 165. Gansu Fuzheng Pharmaceutical Technology Co., Ltd. Coptis Pill for Clearing the Upper Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 166. Gansu Fuzheng Pharmaceutical Technology Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio Table 167. Gansu Fuzheng Pharmaceutical Technology Co., Ltd. Recent Development Table 168. Dong'e Ejiao Co., Ltd. Company Information Table 169. Dong'e Ejiao Co., Ltd. Business Overview Table 170. Dong'e Ejiao Co., Ltd. Coptis Pill for Clearing the Upper Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 171. Dong'e Ejiao Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio Table 172. Dong'e Ejiao Co., Ltd. Recent Development Table 173. Beijing Tongrentang Co., Ltd. Company Information Table 174. Beijing Tongrentang Co., Ltd. Business Overview Table 175. Beijing Tongrentang Co., Ltd. Coptis Pill for Clearing the Upper Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 176. Beijing Tongrentang Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio Table 177. Beijing Tongrentang Co., Ltd. Recent Development Table 178. Key Raw Materials Table 179. Raw Materials Key Suppliers Table 180. Coptis Pill for Clearing the Upper Distributors List Table 181. Coptis Pill for Clearing the Upper Customers List Table 182. Research Programs/Design for This Report Table 183. Authors List of This Report Table 184. Secondary Sources Table 185. Primary Sources List of Figures Figure 1. Coptis Pill for Clearing the Upper Product Image Figure 2. Global Coptis Pill for Clearing the Upper Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Coptis Pill for Clearing the Upper Market Size (2021-2032) & (US$ Million) Figure 4. Global Coptis Pill for Clearing the Upper Sales (2021-2032) & (K Units) Figure 5. Global Coptis Pill for Clearing the Upper Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Coptis Pill for Clearing the Upper Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 4g Image Figure 9. 6g Image Figure 10. Global Coptis Pill for Clearing the Upper Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Coptis Pill for Clearing the Upper Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Coptis Pill for Clearing the Upper Sales Market Share by Type (2021-2032) Figure 13. Global Coptis Pill for Clearing the Upper Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Coptis Pill for Clearing the Upper Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Coptis Pill for Clearing the Upper Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Other Image Figure 19. Global Coptis Pill for Clearing the Upper Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Coptis Pill for Clearing the Upper Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Coptis Pill for Clearing the Upper Sales Market Share by Application (2021-2032) Figure 22. Global Coptis Pill for Clearing the Upper Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Coptis Pill for Clearing the Upper Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Coptis Pill for Clearing the Upper Revenue Market Share by Application (2021-2032) Figure 25. North America Coptis Pill for Clearing the Upper Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Coptis Pill for Clearing the Upper Sales Market Share by Country (2021-2032) Figure 27. U.S. Coptis Pill for Clearing the Upper Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Coptis Pill for Clearing the Upper Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Coptis Pill for Clearing the Upper Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Coptis Pill for Clearing the Upper Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Coptis Pill for Clearing the Upper Sales Market Share by Country (2021-2032) Figure 32. Germany Coptis Pill for Clearing the Upper Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Coptis Pill for Clearing the Upper Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Coptis Pill for Clearing the Upper Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Coptis Pill for Clearing the Upper Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Coptis Pill for Clearing the Upper Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Coptis Pill for Clearing the Upper Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Coptis Pill for Clearing the Upper Sales Market Share by Country (2021-2032) Figure 39. China Coptis Pill for Clearing the Upper Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Coptis Pill for Clearing the Upper Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Coptis Pill for Clearing the Upper Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Coptis Pill for Clearing the Upper Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Coptis Pill for Clearing the Upper Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Coptis Pill for Clearing the Upper Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Coptis Pill for Clearing the Upper Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Coptis Pill for Clearing the Upper Sales Market Share by Country (2021-2032) Figure 47. Brazil Coptis Pill for Clearing the Upper Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Coptis Pill for Clearing the Upper Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Coptis Pill for Clearing the Upper Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Coptis Pill for Clearing the Upper Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Coptis Pill for Clearing the Upper Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Coptis Pill for Clearing the Upper Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Coptis Pill for Clearing the Upper Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Coptis Pill for Clearing the Upper Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Coptis Pill for Clearing the Upper Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Coptis Pill for Clearing the Upper Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Coptis Pill for Clearing the Upper Revenue (2021-2032) & (US$ Million) Figure 58. North America Coptis Pill for Clearing the Upper Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Coptis Pill for Clearing the Upper Revenue (2021-2032) & (US$ Million) Figure 60. Europe Coptis Pill for Clearing the Upper Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Coptis Pill for Clearing the Upper Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Coptis Pill for Clearing the Upper Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Coptis Pill for Clearing the Upper Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Coptis Pill for Clearing the Upper Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Coptis Pill for Clearing the Upper Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Coptis Pill for Clearing the Upper Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 4g
  • 6g
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Chongqing Dongfang Pharmaceutical Co., Ltd.
  • Xi'an Beilin Pharmaceutical Co., Ltd.
  • Tonghua Yongji Pharmaceutical Co., Ltd.
  • Shaanxi Xiangju Pharmaceutical Group Co., Ltd.
  • Shaanxi Hanwang Pharmaceutical Co., Ltd.
  • Shanxi Zhenglai Pharmaceutical Co., Ltd.
  • Shanxi Wanhui Pharmaceutical Co., Ltd.
  • Shanxi Huakang Pharmaceutical Co., Ltd.
  • Shandong Wohua Pharmaceutical Technology Co., Ltd.
  • Shandong Huayang Pharmaceutical Co., Ltd.
  • Inner Mongolia Datang Pharmaceutical Co., Ltd.
  • Lanzhou Foci Pharmaceutical Co., Ltd.
  • Jilin Yinhe Pharmaceutical Co., Ltd.
  • Hubei Xianglian Pharmaceutical Co., Ltd.
  • Henan Longdu Pharmaceutical Co., Ltd.
  • Harbin Pharmaceutical Group Traditional Chinese Medicine Factory No. 2
  • Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory
  • Sinopharm Group Zhonglian Pharmaceutical Co., Ltd.
  • Gansu Tianshui Qihuang Pharmaceutical Co., Ltd.
  • Gansu Hexi Pharmaceutical Co., Ltd.
  • Gansu Fuzheng Pharmaceutical Technology Co., Ltd.
  • Dong'e Ejiao Co., Ltd.
  • Beijing Tongrentang Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Coptis Pill for Clearing the Upper Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Coptis Pill for Clearing the Upper Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Coptis Pill for Clearing the Upper Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Coptis Pill for Clearing the Upper Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Coptis Pill for Clearing the Upper Market Dynamics
  1. 2.1 Coptis Pill for Clearing the Upper Industry Trends
  2. 2.2 Coptis Pill for Clearing the Upper Industry Drivers
  3. 2.3 Coptis Pill for Clearing the Upper Industry Opportunities and Challenges
  4. 2.4 Coptis Pill for Clearing the Upper Industry Restraints
3 Coptis Pill for Clearing the Upper Market by Manufacturers
  1. 3.1 Global Coptis Pill for Clearing the Upper Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Coptis Pill for Clearing the Upper Sales by Manufacturers (2021-2026)
  3. 3.3 Global Coptis Pill for Clearing the Upper Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Coptis Pill for Clearing the Upper Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Coptis Pill for Clearing the Upper Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Coptis Pill for Clearing the Upper Manufacturers, Product Type & Application
  7. 3.7 Global Coptis Pill for Clearing the Upper Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Coptis Pill for Clearing the Upper Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Coptis Pill for Clearing the Upper Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Coptis Pill for Clearing the Upper Tier 1, Tier 2, and Tier 3
4 Coptis Pill for Clearing the Upper Market by Type
  1. 4.1 Coptis Pill for Clearing the Upper Type Introduction
  2. 4.1.1 4g
  3. 4.1.2 6g
  4. 4.2 Global Coptis Pill for Clearing the Upper Sales by Type
  5. 4.2.1 Global Coptis Pill for Clearing the Upper Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Coptis Pill for Clearing the Upper Sales by Type (2021-2032)
  7. 4.2.3 Global Coptis Pill for Clearing the Upper Sales Market Share by Type (2021-2032)
  8. 4.3 Global Coptis Pill for Clearing the Upper Revenue by Type
  9. 4.3.1 Global Coptis Pill for Clearing the Upper Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Coptis Pill for Clearing the Upper Revenue by Type (2021-2032)
  11. 4.3.3 Global Coptis Pill for Clearing the Upper Revenue Market Share by Type (2021-2032)
5 Coptis Pill for Clearing the Upper Market by Application
  1. 5.1 Coptis Pill for Clearing the Upper Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Coptis Pill for Clearing the Upper Sales by Application
  6. 5.2.1 Global Coptis Pill for Clearing the Upper Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Coptis Pill for Clearing the Upper Sales by Application (2021-2032)
  8. 5.2.3 Global Coptis Pill for Clearing the Upper Sales Market Share by Application (2021-2032)
  9. 5.3 Global Coptis Pill for Clearing the Upper Revenue by Application
  10. 5.3.1 Global Coptis Pill for Clearing the Upper Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Coptis Pill for Clearing the Upper Revenue by Application (2021-2032)
  12. 5.3.3 Global Coptis Pill for Clearing the Upper Revenue Market Share by Application (2021-2032)
6 Global Coptis Pill for Clearing the Upper Sales by Region
  1. 6.1 Global Coptis Pill for Clearing the Upper Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Coptis Pill for Clearing the Upper Sales by Region (2021-2032)
  3. 6.2.1 Global Coptis Pill for Clearing the Upper Sales by Region (2021-2026)
  4. 6.2.2 Global Coptis Pill for Clearing the Upper Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Coptis Pill for Clearing the Upper Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Coptis Pill for Clearing the Upper Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Coptis Pill for Clearing the Upper Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Coptis Pill for Clearing the Upper Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Coptis Pill for Clearing the Upper Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Coptis Pill for Clearing the Upper Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Coptis Pill for Clearing the Upper Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Coptis Pill for Clearing the Upper Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Coptis Pill for Clearing the Upper Revenue by Region
  1. 7.1 Global Coptis Pill for Clearing the Upper Revenue by Region
  2. 7.1.1 Global Coptis Pill for Clearing the Upper Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Coptis Pill for Clearing the Upper Revenue by Region (2021-2026)
  4. 7.1.3 Global Coptis Pill for Clearing the Upper Revenue by Region (2027-2032)
  5. 7.1.4 Global Coptis Pill for Clearing the Upper Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Coptis Pill for Clearing the Upper Revenue (2021-2032)
  8. 7.2.2 North America Coptis Pill for Clearing the Upper Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Coptis Pill for Clearing the Upper Revenue (2021-2032)
  11. 7.3.2 Europe Coptis Pill for Clearing the Upper Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Coptis Pill for Clearing the Upper Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Coptis Pill for Clearing the Upper Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Coptis Pill for Clearing the Upper Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Coptis Pill for Clearing the Upper Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chongqing Dongfang Pharmaceutical Co., Ltd.
  2. 8.1.1 Chongqing Dongfang Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Chongqing Dongfang Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Chongqing Dongfang Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chongqing Dongfang Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio
  6. 8.1.5 Chongqing Dongfang Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Xi'an Beilin Pharmaceutical Co., Ltd.
  8. 8.2.1 Xi'an Beilin Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Xi'an Beilin Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Xi'an Beilin Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Xi'an Beilin Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio
  12. 8.2.5 Xi'an Beilin Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Tonghua Yongji Pharmaceutical Co., Ltd.
  14. 8.3.1 Tonghua Yongji Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Tonghua Yongji Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Tonghua Yongji Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Tonghua Yongji Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio
  18. 8.3.5 Tonghua Yongji Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Shaanxi Xiangju Pharmaceutical Group Co., Ltd.
  20. 8.4.1 Shaanxi Xiangju Pharmaceutical Group Co., Ltd. Company Information
  21. 8.4.2 Shaanxi Xiangju Pharmaceutical Group Co., Ltd. Business Overview
  22. 8.4.3 Shaanxi Xiangju Pharmaceutical Group Co., Ltd. Coptis Pill for Clearing the Upper Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shaanxi Xiangju Pharmaceutical Group Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio
  24. 8.4.5 Shaanxi Xiangju Pharmaceutical Group Co., Ltd. Recent Developments
  25. 8.5 Shaanxi Hanwang Pharmaceutical Co., Ltd.
  26. 8.5.1 Shaanxi Hanwang Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Shaanxi Hanwang Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Shaanxi Hanwang Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shaanxi Hanwang Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio
  30. 8.5.5 Shaanxi Hanwang Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Shanxi Zhenglai Pharmaceutical Co., Ltd.
  32. 8.6.1 Shanxi Zhenglai Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Shanxi Zhenglai Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Shanxi Zhenglai Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shanxi Zhenglai Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio
  36. 8.6.5 Shanxi Zhenglai Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Shanxi Wanhui Pharmaceutical Co., Ltd.
  38. 8.7.1 Shanxi Wanhui Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Shanxi Wanhui Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Shanxi Wanhui Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shanxi Wanhui Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio
  42. 8.7.5 Shanxi Wanhui Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Shanxi Huakang Pharmaceutical Co., Ltd.
  44. 8.8.1 Shanxi Huakang Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Shanxi Huakang Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Shanxi Huakang Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Shanxi Huakang Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio
  48. 8.8.5 Shanxi Huakang Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Shandong Wohua Pharmaceutical Technology Co., Ltd.
  50. 8.9.1 Shandong Wohua Pharmaceutical Technology Co., Ltd. Company Information
  51. 8.9.2 Shandong Wohua Pharmaceutical Technology Co., Ltd. Business Overview
  52. 8.9.3 Shandong Wohua Pharmaceutical Technology Co., Ltd. Coptis Pill for Clearing the Upper Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Shandong Wohua Pharmaceutical Technology Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio
  54. 8.9.5 Shandong Wohua Pharmaceutical Technology Co., Ltd. Recent Developments
  55. 8.10 Shandong Huayang Pharmaceutical Co., Ltd.
  56. 8.10.1 Shandong Huayang Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Shandong Huayang Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Shandong Huayang Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Shandong Huayang Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio
  60. 8.10.5 Shandong Huayang Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 Inner Mongolia Datang Pharmaceutical Co., Ltd.
  62. 8.11.1 Inner Mongolia Datang Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Inner Mongolia Datang Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Inner Mongolia Datang Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Inner Mongolia Datang Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio
  66. 8.11.5 Inner Mongolia Datang Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Lanzhou Foci Pharmaceutical Co., Ltd.
  68. 8.12.1 Lanzhou Foci Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Lanzhou Foci Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Lanzhou Foci Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Lanzhou Foci Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio
  72. 8.12.5 Lanzhou Foci Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Jilin Yinhe Pharmaceutical Co., Ltd.
  74. 8.13.1 Jilin Yinhe Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Jilin Yinhe Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Jilin Yinhe Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Jilin Yinhe Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio
  78. 8.13.5 Jilin Yinhe Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Hubei Xianglian Pharmaceutical Co., Ltd.
  80. 8.14.1 Hubei Xianglian Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Hubei Xianglian Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Hubei Xianglian Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Hubei Xianglian Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio
  84. 8.14.5 Hubei Xianglian Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 Henan Longdu Pharmaceutical Co., Ltd.
  86. 8.15.1 Henan Longdu Pharmaceutical Co., Ltd. Company Information
  87. 8.15.2 Henan Longdu Pharmaceutical Co., Ltd. Business Overview
  88. 8.15.3 Henan Longdu Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Henan Longdu Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio
  90. 8.15.5 Henan Longdu Pharmaceutical Co., Ltd. Recent Developments
  91. 8.16 Harbin Pharmaceutical Group Traditional Chinese Medicine Factory No. 2
  92. 8.16.1 Harbin Pharmaceutical Group Traditional Chinese Medicine Factory No. 2 Company Information
  93. 8.16.2 Harbin Pharmaceutical Group Traditional Chinese Medicine Factory No. 2 Business Overview
  94. 8.16.3 Harbin Pharmaceutical Group Traditional Chinese Medicine Factory No. 2 Coptis Pill for Clearing the Upper Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Harbin Pharmaceutical Group Traditional Chinese Medicine Factory No. 2 Coptis Pill for Clearing the Upper Product Portfolio
  96. 8.16.5 Harbin Pharmaceutical Group Traditional Chinese Medicine Factory No. 2 Recent Developments
  97. 8.17 Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory
  98. 8.17.1 Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Company Information
  99. 8.17.2 Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Business Overview
  100. 8.17.3 Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Coptis Pill for Clearing the Upper Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Coptis Pill for Clearing the Upper Product Portfolio
  102. 8.17.5 Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Recent Developments
  103. 8.18 Sinopharm Group Zhonglian Pharmaceutical Co., Ltd.
  104. 8.18.1 Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Company Information
  105. 8.18.2 Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Business Overview
  106. 8.18.3 Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio
  108. 8.18.5 Sinopharm Group Zhonglian Pharmaceutical Co., Ltd. Recent Developments
  109. 8.19 Gansu Tianshui Qihuang Pharmaceutical Co., Ltd.
  110. 8.19.1 Gansu Tianshui Qihuang Pharmaceutical Co., Ltd. Company Information
  111. 8.19.2 Gansu Tianshui Qihuang Pharmaceutical Co., Ltd. Business Overview
  112. 8.19.3 Gansu Tianshui Qihuang Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Gansu Tianshui Qihuang Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio
  114. 8.19.5 Gansu Tianshui Qihuang Pharmaceutical Co., Ltd. Recent Developments
  115. 8.20 Gansu Hexi Pharmaceutical Co., Ltd.
  116. 8.20.1 Gansu Hexi Pharmaceutical Co., Ltd. Company Information
  117. 8.20.2 Gansu Hexi Pharmaceutical Co., Ltd. Business Overview
  118. 8.20.3 Gansu Hexi Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Gansu Hexi Pharmaceutical Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio
  120. 8.20.5 Gansu Hexi Pharmaceutical Co., Ltd. Recent Developments
  121. 8.21 Gansu Fuzheng Pharmaceutical Technology Co., Ltd.
  122. 8.21.1 Gansu Fuzheng Pharmaceutical Technology Co., Ltd. Company Information
  123. 8.21.2 Gansu Fuzheng Pharmaceutical Technology Co., Ltd. Business Overview
  124. 8.21.3 Gansu Fuzheng Pharmaceutical Technology Co., Ltd. Coptis Pill for Clearing the Upper Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Gansu Fuzheng Pharmaceutical Technology Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio
  126. 8.21.5 Gansu Fuzheng Pharmaceutical Technology Co., Ltd. Recent Developments
  127. 8.22 Dong'e Ejiao Co., Ltd.
  128. 8.22.1 Dong'e Ejiao Co., Ltd. Company Information
  129. 8.22.2 Dong'e Ejiao Co., Ltd. Business Overview
  130. 8.22.3 Dong'e Ejiao Co., Ltd. Coptis Pill for Clearing the Upper Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Dong'e Ejiao Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio
  132. 8.22.5 Dong'e Ejiao Co., Ltd. Recent Developments
  133. 8.23 Beijing Tongrentang Co., Ltd.
  134. 8.23.1 Beijing Tongrentang Co., Ltd. Company Information
  135. 8.23.2 Beijing Tongrentang Co., Ltd. Business Overview
  136. 8.23.3 Beijing Tongrentang Co., Ltd. Coptis Pill for Clearing the Upper Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Beijing Tongrentang Co., Ltd. Coptis Pill for Clearing the Upper Product Portfolio
  138. 8.23.5 Beijing Tongrentang Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Coptis Pill for Clearing the Upper Value Chain Analysis
  2. 9.1.1 Coptis Pill for Clearing the Upper Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Coptis Pill for Clearing the Upper Production Mode & Process
  6. 9.2 Coptis Pill for Clearing the Upper Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Coptis Pill for Clearing the Upper Distributors
  9. 9.2.3 Coptis Pill for Clearing the Upper Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst